Aug 09, 2023 / 12:30PM GMT
Operator
Hello, and welcome to the Medicenna Therapeutics MDNA11 clinical trial update call. All participants are now in listen only mode. There will be a Q&A session at the end of the prepared remarks. Please be advised this call is being recorded at the company's request. I would now like to turn the call over to Alexander Morin of Russo Partners. Please go ahead.
Alexander Morin - Russo Partners - IR
Thank you, operator, and thank you all for participating in today's conference call. This morning Medicenna issued a press release providing an update on is MDNA11 clinical trial. If you have not seen yet the press release, it is available on the Investor page of media centers website. Before we begin, I would like to remind you that certain statements and information shared during this call constitute forward-looking information within the meaning of applicable securities laws. All statements other than statements of historical facts shared during this call.
And that relate to the future operations of the company and other statements that are not historical
Medicenna Therapeutics Corp MDNA11 Clinical Update Call Transcript
Aug 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers